Search by Drug Name or NDC

    NDC 00093-5732-01 Oxycodone Hydrochloride 20 mg/1 Details

    Oxycodone Hydrochloride 20 mg/1

    Oxycodone Hydrochloride is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is OXYCODONE HYDROCHLORIDE.

    Product Information

    NDC 00093-5732
    Product ID 0093-5732_7331dcb7-b48a-4c89-91fc-9119a4af0aa6
    Associated GPIs 6510007510A720
    GCN Sequence Number 072864
    GCN Sequence Number Description oxycodone HCl TAB ER 12H 20 MG ORAL
    HIC3 H3A
    HIC3 Description OPIOID ANALGESICS
    GCN 37161
    HICL Sequence Number 001742
    HICL Sequence Number Description OXYCODONE HCL
    Brand/Generic Generic
    Proprietary Name Oxycodone Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxycodone Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name OXYCODONE HYDROCHLORIDE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Full Opioid Agonists [MoA], Opioid Agonist [EPC]
    DEA Schedule CII
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA022272
    Listing Certified Through n/a

    Package

    NDC 00093-5732-01 (00093573201)

    NDC Package Code 0093-5732-01
    Billing NDC 00093573201
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5732-01)
    Marketing Start Date 2015-10-12
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 4.05047
    Pricing Unit EA
    Effective Date 2021-08-18
    NDC Description OXYCODONE HCL ER 20 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 6
    Classification for Rate Setting G
    As of Date 2022-08-10
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis